Partnership agreement signed with WEGO Holding for clinical chemistry analyzers
Release Date: 2025/04/04
On March 28, 2025, JEOL Ltd. (President & CEO: Izumi Oi) has signed a partnership agreement with WEGO Shingene Medical Technology Co., Ltd. (Shandong, China), a subsidiary of WEGO Holding, to expand the market for clinical chemistry analyzers in China.
WEGO Holding is a comprehensive medical device manufacturer that globally offers over 1,000 types of medical devices and pharmaceuticals, covering clinical care, orthopedics, blood purification and others. The IVD (In Vitro Diagnostics) business, a key pillar of WEGO Shingene Medical Technology Co., Ltd., focuses on the research, development, manufacturing, and sales of clinical diagnostic reagents and testing equipment.
Through this partnership agreement with WEGO Shingene Medical Technology Co., Ltd., JEOL aims to leverage its expertise in manufacturing clinical chemistry analyzers and integrate it with WEGO Holding's advantage in their extensive network and deep understanding of the Chinese market. This synergy will empower us to create more innovative products and services, driving the further development of the medical device industry in China.
Related Products
Are you a medical professional or personnel engaged in medical care?
No
Please be reminded that these pages are not intended to provide the general public with information about the products.